Skip to main content
. Author manuscript; available in PMC: 2024 Sep 3.
Published in final edited form as: AIDS Res Hum Retroviruses. 2023 Mar 22;39(10):525–532. doi: 10.1089/AID.2022.0149

Table 1.

Baseline Characteristics of the Matched Population (Comparing Those Ever Enrolling in Community Adherence Support Groups with Those Never Enrolling in a Community Adherence Support Group) (n = 26,858)

All (n = 26,858) Non-CASG members (n = 13,429) CASG members (n = 13,429)

Sex, n (%)
 Female 20,020 (74.5) 10,051 (74.8) 9,969 (74.2)
 Male 6,838 (25.5) 3,378 (25.2) 3,460 (25.8)
Age at CASG eligibility (years), median [IQR] 31.9 [25.9–40.0] 31.5 [25.6–39.5] 32.5 [26.4–40.4]
Age at CASG eligibility (years), n (%)
 15–19 1,223 (4.55) 731 (5.4) 492 (3.7)
 20–24 4,469 (16.6) 2,346 (17.5) 2,123 (15.8)
 25–49 18,908 (70.4) 9,231 (68.7) 9,67, (72.1)
 50+ 2,258 (8.4) 1,121 (8.4) 1,137 (8.5)
Marital status, n (%)
 Cohabitating with partner 9,415 (35.1) 4,773 (35.5) 4,642 (34.6)
 Married 3,516 (13.1) 1,770 (13.2) 1,746 (13.0)
 Separated/divorced/widowed/single 5,974 (22.2) 2,900 (21.6) 3,074 (22.9)
 Missing 7,953 (29.6) 3,986 (29.7) 3,967 (29.5)
Highest educational level attained, n (%)
 None 5,397 (20.1) 2,593 (19.3) 2,804 (20.9)
 Primary school 12,290 (45.8) 6,142 (45.7) 6,148 (45.8)
 Post-secondary 2,937 (10.9) 1,569 (11.7) 1,368 (10.2)
 Missing 6,234 (23.2) 3,125 (23.3) 3,109 (23.2)
CD4 cell count (cells/mm3), median [IQR] 375 [231–555] 376 [232–556] 373 [230–554]
CD4 cell count (cells/mm3), n (%)
 <200 3,666 (13.6) 1,779 (13.2) 1,887 (14.1)
 200–349 4,715 (17.6) 2,277 (17.0) 2,438 (18.2)
 350–499 4,156 (15.5) 1,994 (14.8) 2,162 (16.1)
 ≥500 5,712 (21.3) 2,804 (20.9) 2,908 (21.7)
 Missing 8,609 (32.1) 4,575 (34.1) 4,034 (30)
TB infection status at enrollment, n (%)
 No 23,232 (86.5) 11,502 (85.7) 11,730 (87.3)
 Yes 3,440 (12.8) 1,799 (13.4) 1,641 (12.2)
 Missing 186 (0.7) 128 (1.0) 58 (0.4)
Health facility location—district, n (%)
 Gilé 1,920 (7.2) 960 (7.2) 960 (7.2)
 Ile 1,102 (4.1) 551 (4.1) 551 (4.1)
 Inhassunge 2,240 (8.3) 1,120 (8.34) 1,120 (8.3)
 Maganja da Costa 2,964 (11) 1482 (11) 1,482 (11)
 Mocubela 2,806 (10.4) 1,403 (10.4) 1,403 (10.4)
 Alto Molócué 1,244 (4.6) 622 (4.6) 622 (4.6)
 Namacurra 4,344 (16.2) 2,172 (16.2) 2,172 (16.2)
 Pebane 5,936 (22.1) 2,968 (22.1) 2,968 (22.1)
 Quelimane 4,302 (16) 2,151 (16) 2,151 (16)
Health facility location, n (%)
 Periurban Quelimanea 1,055 (3.9) 534 (4) 521 (3.9)
 Semiurban Quelimaneb 3,262 (12.1) 1,623 (12.1) 1,639 (12.2)
 Rural districts 22,541 (83.9) 11,272 (83.9) 11,269 (83.9)
Time to first VL (days), median [IQR]c 351 [165–645] 358 [163–687] 344 [169–606]
Time to CASG eligibility (days), median [IQR] 276 [188–640] 273 [184–644] 279 [194–636]
Year of CASG eligibility, n (%)
 ≤2013 2,678 (10) 1,543 (11.5) 1,135 (8.45)
 2014 4,733 (17.6) 2,583 (19.2) 2,150 (16)
 2015 6,133 (22.8) 3,209 (23.9) 2,924 (21.8)
 2016 6,570 (24.5) 3,184 (23.7) 3,386 (25.2)
 ≥2017 6,744 (25.1) 2,910 (21.7) 3,834 (28.6)
a

Periurban: urban health facilities in Quelimane District.

b

Semiurban: peripheral health facilities in Quelimane District.

c

Time to VL is derived from VL measurements obtained from 4,748 patients, which were used in the viral suppression analysis.

CASG, community adherence support group; CI, confidence interval; IQR, interquartile range; OR, odds ratio; TB, tuberculosis; VL, viral load.